Famvir
(Famciclovir)ApprovedSmall molecule
NovartisFamciclovir is used to treat infections caused by herpes viruses, including cold sores, genital herpes, and shingles. It works by stopping the virus from multiplying in your body.[2] Famvir is currently approved and in use across 10 indications[4].[1]
Famvir is one of 199 small molecule programs targeting Herpes simplex infection. It is currently in Approved.
10
Indications
20
Total Trials
1
Active Trials
198
Competitors
1
FDA Application
NDA/BLA/ANDA regulatory filings
Pipeline
Status by Indication[4][1]
Indication
Competition
Competitive Landscape
560 competitors in Multiple Sclerosis
#DrugCompanyPhaseTrials
1Famvir
NovartisApproved
Betaseron
BayerPreclinical
Kesimpta
NovartisPreclinical
Tysabri
BiogenPreclinical
Avonex
EMD SeronoPreclinical
Campath
GGenzyme, a Sanofi Company
Preclinical
Zinbryta
RochePreclinical
Flomax
SanofiPreclinical
Novantrone
PfizerPreclinical
Pred Forte
NovartisPreclinical
Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.
Timeline
Expected Milestones
Clinical
Trials by Indication[1]
Genital Herpes4 trials
Herpes simplex infection2 trials
Herpes Zoster2 trials
MCI2 trials
7 more indications
Herpes Labialis2 trials
Randomized1 trial
Treatment1 trial
Famvir for Treatment of Hearing in Unilateral Meniere's Disease
Terminated·—·Phase 3·NCT01526408·11 enrolled
Postherpetic Neuralgia1 trial
Effect of Early Use of Oxycodone During the Acute Phase of Herpes Zoster on Preventing Postherpetic Neuralgia
Unknown status·SSecond Affiliated Hospital, School of Medicine, Zhejiang University·N/A·NCT03120962·140 enrolled
Varicella Zoster1 trial
Regulatory
FDA Approval Timeline[5]
Dec 11, 1995
FAMVIR
NDA NDA020363
Sources
References
- [1]
- [2]MedlinePlus Drug Information — Famvir drug information. U.S. National Library of Medicine, National Institutes of Health.
- [3]
- [4]Open Targets Platform — Drug–disease associations for Famciclovir. EMBL-EBI & Wellcome Sanger Institute.
- [5]
- [6]